For years they said there would be a “cure” for diabetes. There was INGAP therapy, beta cell transplants, Dr. Denise Faustman, and many other promising developments that were supposed to be the next big thing in diabetes. However, it seems that now we are looking to manage diabetes rather than …

I don’t know how many times I have the opportunity to teach patients and health care providers that it’s not all about food. I was recently reminded of that when I overheard a dietitian, a CDE, go over a 4-week CGM report with a patient, male, 53 years of age, type 2 diabetes, non-obese, actually not even overweight.

In part 2 of this Exclusive Interview, Michael Hill explains what the hybrid closed-loop system can and can't do as well as some of the benefits.

In this week's Homerun Slides, successful - and unsuccessful - medications and clinical trials.

Transcriptional regulation of gluconeogenesis: The gradual shift from the fed-to-fasted state is followed closely by hormonal regulation of genes encoding PEPCK, fructose-1,6-bisphosphatase, and the glucose-6-phosphatase catalytic subunit. The transcriptional regulation of these genes remains a developing research area and its many emerging nuances cannot be completely covered here.